SCI Abstract

search
+
Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study
Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study
The underlying connections between obesity and non-alcoholic fatty liver disease (NAFLD) are not fully understood. One pot...
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
The international consensus to revise non-alcoholic fatty liver disease to metabolic (dysfunction)-associated fatty liver ...
Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis
Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis
Limited data exists regarding impact of graft type on outcomes following liver transplantation (LT) in Primary Sclerosing ...
Optimal threshold of portal pressure gradient for patients with ascites after covered TIPS: a multicentre cohort study
Optimal threshold of portal pressure gradient for patients with ascites after covered TIPS: a multicentre cohort study
Transjugular intrahepatic portosystemic shunt (TIPS) is recommended for treating recurrent and refractory ascites. However...
Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice
Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice
Although several therapeutic agents show efficacy in advanced hepatocellular carcinoma (HCC), biomarkers such as comprehen...
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
In Asia–Pacific region, hepatocellular carcinoma is a serious health threat attributing to over 600,000 deaths each ...
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy
Recently, anti-programmed cell death protein-1 (anti-PD-1) and anti-PD-L1 therapies were approved for hepatocellular carci...
The dynamic patterns of metabolic-associated fatty liver disease and its severity and risk of cardiovascular disease
The dynamic patterns of metabolic-associated fatty liver disease and its severity and risk of cardiovascular disease
While metabolic-associated fatty liver disease (MAFLD) is widely recognized as a risk factor for cardiovascular disease (C...
Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis
Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis
Hepatoblastoma is the most common primary liver cancer in children, yet comprehensive understanding of its epidemiology is...
Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
Semaglutide has shown potential liver benefits in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabet...
AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure
AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure
Acute-on-chronic liver failure (ACLF) patients with hepatorenal syndrome (HRS-AKI) have limited response to vasoconstricto...
Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
Hepatic hemangiomas can be classified into three morphologic patterns: focal (congenital hepatic hemangiomas [CHHs]), mult...
The effect of transition timing of regorafenib on treatment outcomes in unresectable hepatocellular carcinoma: a real-world study
The effect of transition timing of regorafenib on treatment outcomes in unresectable hepatocellular carcinoma: a real-world study
Regorafenib is the recommended second-line therapy for unresectable hepatocellular carcinoma (uHCC). Our study aimed to as...
Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial
Nonalcoholic fatty liver disease (NAFLD) is a common liver comorbidity with considerable global consequences. This study e...
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with an...
Prophylaxis of hepatic encephalopathy: current and future drug targets
Prophylaxis of hepatic encephalopathy: current and future drug targets
Hepatic encephalopathy is described by a broad spectrum of neurological and psychiatric aberrations resulting due to advan...
Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
Acute-on-chronic liver failure (ACLF) is a syndrome of liver failure due to an acute hepatic insult leading to liver failu...
Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals
Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals
Non-alcoholic fatty liver disease (NAFLD) is present in lean people. However, the magnitude of the prognostic hepatic and ...
Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD
Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD
Metabolic dysfunction-associated fatty liver disease (MAFLD) and viral hepatitis due to chronic hepatitis B virus (HBV) or...
Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer
Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer
This study conducted molecular subtyping of biliary tract cancer patients based on 19 PANoptosis-related gene signatures. ...
Acute presentation of autoimmune hepatitis –from acute hepatitis to ALF and ACLF-
Acute presentation of autoimmune hepatitis –from acute hepatitis to ALF and ACLF-
Acute presentation of autoimmune hepatitis (AIH) occurs in 22–43% of all AIH cases, and is not a rare condition. Rat...
The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis
The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis
CXCR6+CD8+T cells have been implicated in the pathogenesis of various liver and autoimmune diseases. However, their involv...
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling
Despite increasing knowledge regarding the cellular and molecular mechanisms of liver fibrogenesis, there is currently no ...
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)-related fibrosis is reversible. However, the dynamic morphology ch...
Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma?
Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma?
National Natural Science Foundation of China, NSFC82073345, shuanghu yuan, Natural Science Innovation and Development Join...
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
The applicability of the proposed metabolic dysfunction-associated steatotic liver disease (MASLD) definition has not been...
Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN)
Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN)
Timely diagnosis and management of pediatric acute liver failure (PALF) is of paramount importance to improve survival. Th...
Nomograms should be noted
Nomograms should be noted
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of ...
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
Evidence has proven that liver fibrosis or even cirrhosis can be reversed by anti-HBV treatment. However, the difference o...
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
Acute-on-chronic liver failure (ACLF) is a syndrome that is characterized by the rapid development of organ failures predi...
Load More
format_indent_increase